Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China.
Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China.
Cancer Lett. 2024 Nov 1;604:217243. doi: 10.1016/j.canlet.2024.217243. Epub 2024 Sep 10.
This study evaluated the cellular heterogeneity and molecular mechanisms of hepatocellular carcinoma (HCC). Single cell RNA sequencing (scRNA-seq), transcriptomic data, histone lactylation-related genes were collected from public databases. Cell-cell interaction, trajectory, pathway, and spatial transcriptome analyses were executed. Differential expression and survival analyses were conducted. Western blot, Real-time reverse transcription PCR (qRT-PCR), and Cell Counting Kit 8 (CCK8) assay were used to detect the expression of αSMA, AKR1B10 and its target genes, and verify the roles of AKR1B10 in HCC cells. Hepatic stellate cell (HSC) subgroups strongly interacted with tumor cell subgroups, and their spatial distribution was heterogeneous. Two candidate prognostic genes (AKR1B10 and RMRP) were obtained. LONP1, NPIPB3, and ZSWIM6 were determined as AKR1B10 targets. Besides, the expression levels of AKR1B10 and αSMA were significantly increased in LX-2 + HepG2 and LX-2 + HuH7 groups compared to those in LX-2 group, respectively. sh-AKR1B10 significantly inhibited the HCC cell proliferation and change the expression of AKR1B10 target genes, Bcl-2, Bax, Pan Kla, and H3K18la at protein levels. Our findings unveil the pivotal role of HSCs in HCC pathogenesis through regulating histone lactylation.
这项研究评估了肝细胞癌 (HCC) 的细胞异质性和分子机制。从公共数据库中收集了单细胞 RNA 测序 (scRNA-seq)、转录组数据和组蛋白乳酰化相关基因。进行了细胞-细胞相互作用、轨迹、通路和空间转录组分析。进行了差异表达和生存分析。使用 Western blot、实时逆转录 PCR (qRT-PCR) 和细胞计数试剂盒 8 (CCK8) 测定来检测αSMA、AKR1B10 及其靶基因的表达,并验证 AKR1B10 在 HCC 细胞中的作用。肝星状细胞 (HSC) 亚群与肿瘤细胞亚群强烈相互作用,其空间分布具有异质性。获得了两个候选预后基因 (AKR1B10 和 RMRP)。LONP1、NPIPB3 和 ZSWIM6 被确定为 AKR1B10 的靶基因。此外,与 LX-2 组相比,LX-2+HepG2 和 LX-2+HuH7 组中 AKR1B10 和αSMA 的表达水平显著增加。sh-AKR1B10 显著抑制 HCC 细胞增殖,并改变 AKR1B10 靶基因、Bcl-2、Bax、Pan Kla 和 H3K18la 的蛋白表达水平。我们的研究结果揭示了 HSCs 通过调节组蛋白乳酰化在 HCC 发病机制中的关键作用。